Skip to main content

Table 3 MeSH terms

From: An assessment of the factors affecting the commercialization of cell-based therapeutics: a systematic review protocol

 

Concept 1

Concept 2

Concept 3

Concept 4

Concept 5

Subject heading

Clinical adoption

MeSH: Technology assessment, Biomedical, Cost-Benefit Analysis

Cell-based therapeutics MeSH: Cell- and Tissue-Based Therapy, MeSH: biological therapy, MeSH: Regenerative Medicine

Conventional therapeutics MeSH: Therapeutics, Drug Therapy, Enzyme therapy, Molecular Targeted Therapy, Immunotherapy, Transplantation, Monoclonal Antibodies, Vaccines, biosimilars, small-molecule drugs

Emerging technologies MeSH: technology assessment, Biomedical, High-Cost Technology

Barriers

Keywords

Clinical adoption, implementation, technology assessment, appraisal, tools, methodology, commercialization

Biologics, gene therapy, regenerative medicines, cell- and tissue-based therapy, stem cells, tissue engineering

Medicines, pharmacological agents, organ transplant, monoclonal, vaccine

Translational medical research